1402 related articles for article (PubMed ID: 29290650)
1. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Wang Y; Jin HY; Fang MZ; Wang XF; Chen H; Huang SL; Kong DS; Li M; Zhang X; Sun Y; Wang SM
World J Gastroenterol; 2020 May; 26(17):2064-2081. PubMed ID: 32536775
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
[TBL] [Abstract][Full Text] [Related]
4. Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.
Pattananandecha T; Sirilun S; Duangjitcharoen Y; Sivamaruthi BS; Suwannalert P; Peerajan S; Chaiyasut C
Pharm Biol; 2016 Sep; 54(9):1596-605. PubMed ID: 26794346
[TBL] [Abstract][Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
7. The impact of gut microbiota manipulation with antibiotics on colon tumorigenesis in a murine model.
Lee JG; Eun CS; Jo SV; Lee AR; Park CH; Han DS
PLoS One; 2019; 14(12):e0226907. PubMed ID: 31860645
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
[TBL] [Abstract][Full Text] [Related]
9. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer.
Bader JE; Enos RT; Velázquez KT; Carson MS; Nagarkatti M; Nagarkatti PS; Chatzistamou I; Davis JM; Carson JA; Robinson CM; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G22-G31. PubMed ID: 29025731
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone Restores Gut Microbiota Composition in ETBF Colonized AOM/DSS Mice.
Cho HW; Rhee KJ; Eom YB
J Microbiol Biotechnol; 2020 Nov; 30(11):1640-1650. PubMed ID: 32958727
[TBL] [Abstract][Full Text] [Related]
11. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.
Wei X; Liang J; Liu J; Dai Y; Leng X; Cheng Y; Chi L
J Ethnopharmacol; 2024 May; 326():117995. PubMed ID: 38428656
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharides isolated from Nostoc commune Vaucher inhibit colitis-associated colon tumorigenesis in mice and modulate gut microbiota.
Guo M; Li Z
Food Funct; 2019 Oct; 10(10):6873-6881. PubMed ID: 31584586
[TBL] [Abstract][Full Text] [Related]
13. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota.
Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C
Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153
[TBL] [Abstract][Full Text] [Related]
14. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
Ohishi T; Kishimoto Y; Miura N; Shiota G; Kohri T; Hara Y; Hasegawa J; Isemura M
Cancer Lett; 2002 Mar; 177(1):49-56. PubMed ID: 11809530
[TBL] [Abstract][Full Text] [Related]
16. Role of intestinal microbiome in American ginseng-mediated colon cancer prevention in high fat diet-fed AOM/DSS mice [corrected].
Wang CZ; Huang WH; Zhang CF; Wan JY; Wang Y; Yu C; Williams S; He TC; Du W; Musch MW; Chang EB; Yuan CS
Clin Transl Oncol; 2018 Mar; 20(3):302-312. PubMed ID: 28808878
[TBL] [Abstract][Full Text] [Related]
17. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice.
Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN
World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
19. Differences Between the Intestinal Lumen Microbiota of Aberrant Crypt Foci (ACF)-Bearing and Non-bearing Rats.
Xiao X; Long W; Huang T; Xia T; Ye R; Liu Y; Long H
Dig Dis Sci; 2018 Nov; 63(11):2923-2929. PubMed ID: 30014223
[TBL] [Abstract][Full Text] [Related]
20. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
